128 related articles for article (PubMed ID: 25408419)
1. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.
Read ML; Seed RI; Modasia B; Kwan PP; Sharma N; Smith VE; Watkins RJ; Bansal S; Gagliano T; Stratford AL; Ismail T; Wakelam MJ; Kim DS; Ward ST; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
Mol Carcinog; 2016 Jan; 55(1):15-26. PubMed ID: 25408419
[TBL] [Abstract][Full Text] [Related]
2. The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.
Read ML; Seed RI; Fong JC; Modasia B; Ryan GA; Watkins RJ; Gagliano T; Smith VE; Stratford AL; Kwan PK; Sharma N; Dixon OM; Watkinson JC; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
Endocrinology; 2014 Apr; 155(4):1222-34. PubMed ID: 24506068
[TBL] [Abstract][Full Text] [Related]
3. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
4. Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.
Watkins RJ; Imruetaicharoenchoke W; Read ML; Sharma N; Poole VL; Gentilin E; Bansal S; Bosseboeuf E; Fletcher R; Nieto HR; Mallick U; Hackshaw A; Mehanna H; Boelaert K; Smith VE; McCabe CJ
J Clin Endocrinol Metab; 2016 Dec; 101(12):4551-4563. PubMed ID: 27603901
[TBL] [Abstract][Full Text] [Related]
5. PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer.
Read ML; Modasia B; Fletcher A; Thompson RJ; Brookes K; Rae PC; Nieto HR; Poole VL; Roberts S; Campbell MJ; Boelaert K; Turnell AS; Smith VE; Mehanna H; McCabe CJ
Cancer Res; 2018 Oct; 78(20):5863-5876. PubMed ID: 30154144
[TBL] [Abstract][Full Text] [Related]
6. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
7. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
[TBL] [Abstract][Full Text] [Related]
8. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
9. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.
Read ML; Fong JC; Modasia B; Fletcher A; Imruetaicharoenchoke W; Thompson RJ; Nieto H; Reynolds JJ; Bacon A; Mallick U; Hackshaw A; Watkinson JC; Boelaert K; Turnell AS; Smith VE; McCabe CJ
Oncogene; 2017 Sep; 36(37):5296-5308. PubMed ID: 28504713
[TBL] [Abstract][Full Text] [Related]
10. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
11. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
[TBL] [Abstract][Full Text] [Related]
12. Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21
Oh SJ; Lee MG; Moon JR; Lee CK; Chi SG; Kim HJ
J Gastroenterol Hepatol; 2019 May; 34(5):890-898. PubMed ID: 30226276
[TBL] [Abstract][Full Text] [Related]
13. Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.
Imruetaicharoenchoke W; Fletcher A; Lu W; Watkins RJ; Modasia B; Poole VL; Nieto HR; Thompson RJ; Boelaert K; Read ML; Smith VE; McCabe CJ
Endocr Relat Cancer; 2017 Sep; 24(9):459-474. PubMed ID: 28676500
[TBL] [Abstract][Full Text] [Related]
14. The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner.
Arsic N; Ho-Pun-Cheung A; Lopez-Crapez E; Assenat E; Jarlier M; Anguille C; Colard M; Pezet M; Roux P; Gadea G
PLoS One; 2017; 12(2):e0172125. PubMed ID: 28212429
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
16. The clinical value and biological function of PTTG1 in colorectal cancer.
Ren Q; Jin B
Biomed Pharmacother; 2017 May; 89():108-115. PubMed ID: 28219049
[TBL] [Abstract][Full Text] [Related]
17. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
[TBL] [Abstract][Full Text] [Related]
18. Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.
Huang C; Wu S; Li W; Herkilini A; Miyagishi M; Zhao H; Kasim V
EBioMedicine; 2019 Oct; 48():248-263. PubMed ID: 31521611
[TBL] [Abstract][Full Text] [Related]
19. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]